Cargando…

Toll‐like receptor involvement in adolescent scoliotic facet joint degeneration

Facet joint osteoarthritis is prevalent in young patients with adolescent idiopathic scoliosis (AIS) and might contribute to back pain. Toll‐like receptors (TLR) have been linked to cartilaginous tissue degeneration but their involvement in facet joint osteoarthritis in AIS patients is still unknown...

Descripción completa

Detalles Bibliográficos
Autores principales: Bisson, Daniel G., Sheng, Kai, Kocabas, Semsi, Krock, Emerson, Teles, Alisson, Saran, Neil, Ouellet, Jean A., Haglund, Lisbet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576299/
https://www.ncbi.nlm.nih.gov/pubmed/32853438
http://dx.doi.org/10.1111/jcmm.15733
_version_ 1783597991653801984
author Bisson, Daniel G.
Sheng, Kai
Kocabas, Semsi
Krock, Emerson
Teles, Alisson
Saran, Neil
Ouellet, Jean A.
Haglund, Lisbet
author_facet Bisson, Daniel G.
Sheng, Kai
Kocabas, Semsi
Krock, Emerson
Teles, Alisson
Saran, Neil
Ouellet, Jean A.
Haglund, Lisbet
author_sort Bisson, Daniel G.
collection PubMed
description Facet joint osteoarthritis is prevalent in young patients with adolescent idiopathic scoliosis (AIS) and might contribute to back pain. Toll‐like receptors (TLR) have been linked to cartilaginous tissue degeneration but their involvement in facet joint osteoarthritis in AIS patients is still unknown. We compared baseline gene expression levels of TLRs ‐1, ‐2, ‐4, and ‐6 in scoliotic and non‐scoliotic chondrocytes and found higher expression levels in scoliotic chondrocytes with significantly higher TLR2 levels. Furthermore, TLR expression correlated strongly and significantly with inflammatory and catabolic markers in scoliotic but not in non‐scoliotic chondrocytes. TLR activation with a synthetic TLR2/6 agonist resulted in a robust induction and release of pro‐inflammatory and catabolic factors which exacerbated proteoglycan loss in scoliotic but not in non‐scoliotic cartilage. We also detected a higher abundance of alarmins including S100A8/9 and biglycan in scoliotic cartilage. Finally, the small‐molecule antagonists Sparstolonin B and o‐Vanillin reduced catabolism following induction with naturally occurring alarmins and the synthetic TLR2/6 agonist. The high baseline expression, robust responsiveness and strong and significant correlation with proteases and pro‐inflammatory cytokines suggest that TLRs are key regulators of facet joint degeneration in AIS. Blocking their activity could therefore potentially modify disease progression.
format Online
Article
Text
id pubmed-7576299
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-75762992020-10-23 Toll‐like receptor involvement in adolescent scoliotic facet joint degeneration Bisson, Daniel G. Sheng, Kai Kocabas, Semsi Krock, Emerson Teles, Alisson Saran, Neil Ouellet, Jean A. Haglund, Lisbet J Cell Mol Med Original Articles Facet joint osteoarthritis is prevalent in young patients with adolescent idiopathic scoliosis (AIS) and might contribute to back pain. Toll‐like receptors (TLR) have been linked to cartilaginous tissue degeneration but their involvement in facet joint osteoarthritis in AIS patients is still unknown. We compared baseline gene expression levels of TLRs ‐1, ‐2, ‐4, and ‐6 in scoliotic and non‐scoliotic chondrocytes and found higher expression levels in scoliotic chondrocytes with significantly higher TLR2 levels. Furthermore, TLR expression correlated strongly and significantly with inflammatory and catabolic markers in scoliotic but not in non‐scoliotic chondrocytes. TLR activation with a synthetic TLR2/6 agonist resulted in a robust induction and release of pro‐inflammatory and catabolic factors which exacerbated proteoglycan loss in scoliotic but not in non‐scoliotic cartilage. We also detected a higher abundance of alarmins including S100A8/9 and biglycan in scoliotic cartilage. Finally, the small‐molecule antagonists Sparstolonin B and o‐Vanillin reduced catabolism following induction with naturally occurring alarmins and the synthetic TLR2/6 agonist. The high baseline expression, robust responsiveness and strong and significant correlation with proteases and pro‐inflammatory cytokines suggest that TLRs are key regulators of facet joint degeneration in AIS. Blocking their activity could therefore potentially modify disease progression. John Wiley and Sons Inc. 2020-08-27 2020-10 /pmc/articles/PMC7576299/ /pubmed/32853438 http://dx.doi.org/10.1111/jcmm.15733 Text en © 2020 The Authors. Journal of Cellular and Molecular Medicine published by Foundation for Cellular and Molecular Medicine and John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Bisson, Daniel G.
Sheng, Kai
Kocabas, Semsi
Krock, Emerson
Teles, Alisson
Saran, Neil
Ouellet, Jean A.
Haglund, Lisbet
Toll‐like receptor involvement in adolescent scoliotic facet joint degeneration
title Toll‐like receptor involvement in adolescent scoliotic facet joint degeneration
title_full Toll‐like receptor involvement in adolescent scoliotic facet joint degeneration
title_fullStr Toll‐like receptor involvement in adolescent scoliotic facet joint degeneration
title_full_unstemmed Toll‐like receptor involvement in adolescent scoliotic facet joint degeneration
title_short Toll‐like receptor involvement in adolescent scoliotic facet joint degeneration
title_sort toll‐like receptor involvement in adolescent scoliotic facet joint degeneration
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576299/
https://www.ncbi.nlm.nih.gov/pubmed/32853438
http://dx.doi.org/10.1111/jcmm.15733
work_keys_str_mv AT bissondanielg tolllikereceptorinvolvementinadolescentscolioticfacetjointdegeneration
AT shengkai tolllikereceptorinvolvementinadolescentscolioticfacetjointdegeneration
AT kocabassemsi tolllikereceptorinvolvementinadolescentscolioticfacetjointdegeneration
AT krockemerson tolllikereceptorinvolvementinadolescentscolioticfacetjointdegeneration
AT telesalisson tolllikereceptorinvolvementinadolescentscolioticfacetjointdegeneration
AT saranneil tolllikereceptorinvolvementinadolescentscolioticfacetjointdegeneration
AT ouelletjeana tolllikereceptorinvolvementinadolescentscolioticfacetjointdegeneration
AT haglundlisbet tolllikereceptorinvolvementinadolescentscolioticfacetjointdegeneration